Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Mycoses|November 27, 2018
Managing liver dysfunction in haematology patients: Switch antifungals, or use the tincture of time?Anthony J Perissinotti, Bernard L MariniThe Annals of Pharmacotherapy|September 3, 2010
Role of intrathecal rituximab and trastuzumab in the management of leptomeningeal carcinomatosisAnthony J Perissinotti, David J ReevesJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 1, 2016
Expanding the armamentarium for chronic lymphocytic leukemia: A review of novel agents in the management of chronic lymphocytic leukemiaBernard L Marini, Lisa Samanas, Anthony J PerissinottiJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 11, 2014
Characterizing human herpes virus 6 following hematopoietic stem cell transplantationAnthony J Perissinotti, Alison Gulbis, Elizabeth J Shpall, et al.The Annals of Pharmacotherapy|February 23, 2012
Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacementAnthony J Perissinotti, Bryan Dotson, Frank A Baciewicz, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 2, 2016
Successful reintroduction of blinatumomab in a patient with relapsed/refractory acute lymphoblastic leukemia following grade 4 cytokine release syndromeBernard L Marini, Yihan Sun, Patrick W Burke, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 7, 2017
A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemiaRyan K DasGupta, Bernard L Marini, Joslyn Rudoni, et al.Leukemia|November 4, 2024
Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?Firas El Chaer, Anthony J Perissinotti, Sanam Loghavi, et al.Leukemia & Lymphoma|October 19, 2017
Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemiaWanda Salzer, Bruce Bostrom, Yoav Messinger, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 17, 2015
Successful use of high-dose cytarabine in a patient with acute myeloid leukemia and severe hepatic dysfunctionJacob A Barker, Bernard L Marini, Dale Bixby, et al.Pageof 7